Literature DB >> 17547717

Establishment and characterization of a cell line (DEOC-1) originating from a human malignant melanoma of the skin.

Seiji Maeshima1, Takashi Yamada, Kimihiro Kiyokane, Hiroshi Mori.   

Abstract

A new human malignant melanoma cell line, designated DEOC-1, was established from the heel lesion of a 59-year-old man. This cell line has grown well for 84 months. The monolayer, cultured cells are polygonal in shape, appear to be spindle-shaped cells or multipolar cells, and have a tendency to pile up without contact inhibition. The cells are aneuploid, and the modal chromosomal number is in the hyper-triploid range. The cells were transplanted into the subcutis of SCID mice and produced tumors resembling the original tumor. The DEOC-1 cells (1 x 10(6)/5 mL) produced 5-S-cysteinyldopa (5-S-CD). The cells were not sensitive in vitro to any anticancer drug currently used for the treatment of malignant melanoma. Increases in both the protein and the transcriptional levels (mRNA) of multidrug resistance-related genes (multidrug resistance gene 1, multidrug resistance-associated protein 1 and lung resistance-related protein) were observed in DEOC-1 cells. The DEOC-1 cells are well characterized and are a very useful material for basic research of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547717     DOI: 10.1111/j.1749-0774.2007.00028.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  36 in total

1.  Pharmacokinetics of actinoymcin D in patients with malignant melanoma.

Authors:  M H Tattersall; J E Sodergren; S K Dengupta; D H Trites; E J Modest; E Frei
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

2.  Pharmacokinetics of carboplatin after i.v. administration.

Authors:  F Elferink; W J van der Vijgh; I Klein; J B Vermorken; H E Gall; H M Pinedo
Journal:  Cancer Treat Rep       Date:  1987-12

3.  Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats.

Authors:  Hiroshi Masuda; Shiro Fujihira; Hiroshi Ueno; Mitsuo Kagawa; Yoji Katsuoka; Hiroshi Mori
Journal:  Med Electron Microsc       Date:  2003-09

4.  Establishment and characterization of melanoma cell line derived from malignant melanoma of human uterine cervix.

Authors:  K Kiguchi; I Ishiwata; C Ishiwata; Y Tokieda; M Iguchi; R Suzuki; M Saga; H Ishikawa
Journal:  Hum Cell       Date:  1998-06       Impact factor: 4.174

5.  Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors:  H Breithaupt; A Dammann; K Aigner
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  The establishment and characterization of a cell line and mouse xenografts from a human malignant melanoma.

Authors:  D McCormick; I Wallace; J Kirk; S Dinsmore; I Allen
Journal:  Br J Exp Pathol       Date:  1983-02

7.  Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.

Authors:  D J Stewart; D Nundy; J A Maroun; L Tetreault; J Prior
Journal:  Cancer Treat Rep       Date:  1985-03

8.  Primary malignant melanoma of the oral cavity. Case report and establishment of melanoma cell line.

Authors:  T Tagawa; R Yatani; H Nishioka; M Murata
Journal:  Int J Oral Surg       Date:  1981

9.  Establishment and characterization of an uveal-melanoma cell line.

Authors:  I De Waard-Siebinga; D J Blom; M Griffioen; P I Schrier; E Hoogendoorn; G Beverstock; E H Danen; M J Jager
Journal:  Int J Cancer       Date:  1995-07-17       Impact factor: 7.396

10.  Establishment of three rat soft tissue tumor cell lines with different degrees of myogenic differentiation.

Authors:  Y Nagashima; Y Miyagi; K Yu; I Aoki; N Yoshida; T Koshino; S Watanabe; Y Kuchino; K Misugi
Journal:  Pathol Res Pract       Date:  1994-11       Impact factor: 3.250

View more
  3 in total

1.  Novel amelanotic and melanotic cell lines NM78-AM and NM78-MM derived from a human oral malignant melanoma.

Authors:  Taka Nakahara; Yuichi Tamaki; Noriko Tominaga; Yoshiaki Ide; Masanori Nasu; Akihiro Ohyama; Soh Sato; Isamu Ishiwata; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2010-02-01       Impact factor: 4.174

2.  Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice.

Authors:  Paula J Foster; Elizabeth A Dunn; Kristina E Karl; Jonatan A Snir; Colleen M Nycz; Alfred J Harvey; Ron J Pettis
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

3.  Gene Expression and Methylation Analysis in Melanomas and Melanocytes From the Same Patient: Loss of NPM2 Expression Is a Potential Immunohistochemical Marker for Melanoma.

Authors:  Susumu Fujiwara; Hiroshi Nagai; Haruki Jimbo; Naoe Jimbo; Tomoyo Tanaka; Masukazu Inoie; Chikako Nishigori
Journal:  Front Oncol       Date:  2019-01-21       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.